Back

Intra-Cellular Therapies Stock Predictions

Unlock the power of "two-minute trades"

Learn how today!

Sell

ITCI
Intra-Cellular Therapies

Last Price:

$94.86

Seasonality Move:

2.9%

7 Day Trial

ALL ACCESS PASS

$ 7

Free Stock Analysis Report: See The True Value of Any Stock

Analyze Any Stock Free

Intra-Cellular Therapies Stock Forecast

Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 31.2% based on the past 10 years of stock performance.
Intra-Cellular Therapies has risen higher in 8 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
Is Intra-Cellular Therapies Stock Undervalued?

The current Intra-Cellular Therapies [ITCI] share price is $94.87. The Score for ITCI is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
ITCI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Intra-Cellular Therapies Stock Go Up Next Year?

Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 31.2% based on the past 10 years of stock performance.

Intra-Cellular Therapies Stock Rating

Sell

Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies overpriced?

Intra-Cellular Therapies has risen higher in 8 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%

Intra-Cellular Therapies Stock Price History

Is ITCI stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

intracellulartherapies.com

52-Week Data

52-Week High:

98.40

52-Week Low:

62.78

Prediction Charts

Market Cap:

10.1B

Price in USD:

94.87

Volume:

4.1M

Beta:

1.04

Technical Analysis

SMA50:

85.48

SMA100:

80.00

SMA200:

75.72

52-Wk Change:

40.38%

Stock Predictions

Is Intra-Cellular Therapies stock public?

Yes, Intra-Cellular Therapies is a publicly traded company.
What is the Intra-Cellular Therapies stock quote today?

The Intra-Cellular Therapies stock price is 94.87 USD today.
How to buy Intra-Cellular Therapies stock online?

You can buy Intra-Cellular Therapies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Dec-19	86.59	84.14	87.95	83.42
Dec-20	84.54	83.49	85.03	82.76
Dec-23	83.86	84.00	84.52	83.06
Dec-24	83.93	85.24	85.78	83.46
Dec-26	84.60	86.00	86.36	84.41
Dec-27	85.62	84.85	86.26	84.14
Dec-30	84.21	83.48	84.86	82.32
Dec-31	83.67	83.52	84.70	83.05
Jan-2	84.16	84.24	84.99	83.75
Jan-3	84.59	83.72	84.64	82.76
Jan-6	83.71	81.78	83.76	81.40
Jan-7	81.68	83.23	84.19	80.83
Jan-8	83.00	82.56	83.05	81.86
Jan-10	86.53	94.87	98.40	86.25

Intra-Cellular Therapies Earnings

Intra-Cellular Therapies Earnings Report: Per Share Intra-Cellular Therapies Earnings Q1 Q2 Q3 and Q4 last year and next year.

Intra-Cellular Therapies Forecast Revenue Growth

Intra-Cellular Therapies Stock Analysis: Historical quarterly revenues per share for Intra-Cellular Therapies and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.92 per share, and an increase next year of $3.25 per share.

* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.